Support Center
We are here for you. Get the most out of Med-Stop.
Appendix C to Part 40 — DOT Drug-Testing Semi-Annual Laboratory Report to DOT
Cross References:
* Link to an amendment published at 88 FR 27651, May 2, 2023.
* Link to an amendment published at 88 FR 27652, May 2, 2023.
Submission Instructions:
Mail, fax, or email your report to:
U.S. Department of Transportation
Office of Drug and Alcohol Policy and Compliance
W62–300, 1200 New Jersey Avenue SE, Washington, DC 20590
Fax: (202) 366–3897
Email: ODAPCWebMail@dot.gov
Required Items for Each Report:
* Reporting Period: (inclusive dates)
* Laboratory Identification: (name and address)
1. DOT Specimen Results Reported (total number)
2. Negative Results Reported (total number)
* Negative (number)
* Negative-Dilute (number)
3. Rejected for Testing Results Reported (total number)
* By Reason:
* (a) Fatal Flaw (number)
* (b) Uncorrected Flaw (number)
4. Positive Results Reported (total number)
* By Drug:
* (a) Marijuana Metabolite (number)
* (b) Cocaine Metabolite (number)
* (c) Opioids (number)
1. Codeine (number)
2. Morphine (number)
3. 6–AM (number)
4. Hydrocodone (number)
5. Hydromorphone (number)
6. Oxycodone (number)
7. Oxymorphone (number)
* (d) Phencyclidine (number)
* (e) Amphetamines (number)
1. Amphetamine (number)
2. Methamphetamine (number)
3. MDMA (number)
4. MDA (number)
5. Adulterated Results Reported (total number)
* By Reason (number)
6. Substituted Results Reported (total number)
7. Invalid Results Reported (total number)
* By Reason (number)
[82 FR 52247, November 13, 2017]